Clinical Trial Update: CPG 7909 Injection in Melanoma [Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 2 trial of CPG 7909 Injection in melanoma. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CPG 7909 Injection (CpG 7909)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Melanoma | Phase 2 | Status: COMPLETED